GSE164505 GSE164506 indisulam 3 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE164505_GSE164506_indisulam_3_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE164505_GSE164506_indisulam_3_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE164505_GSE164506_indisulam_3_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE164505_GSE164506_indisulam_3_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

maternally expressed 3

Gene

MT-CO2 pseudogene 12

Gene

MT-ATP6 pseudogene 1

Gene

HOX transcript antisense RNA

Gene

MT-ND2 pseudogene 28

Gene

zinc finger protein 826, pseudogene

Gene

TSPEAR antisense RNA 1

Gene

MT-ND1 pseudogene 23

Gene

tumor suppressing subtransferable candidate 2 (pseudogene)

Gene

L-threonine dehydrogenase (pseudogene)

  • Gene

    maternally expressed 3


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    HOX transcript antisense RNA


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    zinc finger protein 826, pseudogene


  • Gene

    TSPEAR antisense RNA 1


  • Gene

    MT-ND1 pseudogene 23


  • Gene

    tumor suppressing subtransferable candidate 2 (pseudogene)


  • Gene

    L-threonine dehydrogenase (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.